Atlas Trials

First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer

Clinical trial NCT01853813 · COMPLETED

Trial details

NCT number
NCT01853813
Sponsor
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Stage II
Start date
2013-05-01
Primary completion
2015-05-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.